advertisement
On GameSpot: 12 free MMOGs you should check out
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement

Content provided in partnership with
Thomson / Gale

Paradigm Genetics Inc

BT Catalyst,  Dec, 2001  

* Paradigm Genetics Inc. (Nasdaq: PDGM) of Research Triangle Park has received its first U.S. Patent. Patent 6,303,365, titled "Method of determining activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase," is for a gene that produces a potential herbicide target protein.

Most Popular Articles in Technology
An overview of continuous data protection
Why all those current ratings?
Many countries now have a mobile penetration rate above 100%, report says
The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
More »
advertisement

It was discovered jointly by Paradigm and Bayer AG of Leverkusan, Germany, through a commercial partnership.

COPYRIGHT 2001 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning